Decision Support on End-of-life Care Planning in Older Adults
- Disease/Condition
- Chronic Obstructive Pulmonary Disease
- Drug/Device/Intervention
- COPD Patient Decision Aid
- Study type
- Interventional
- Intervention type
- other
- Primary sponsor
- National Taipei University of Nursing and Health Sciences
- Phase
- N/A
- Start date
- Mar 10, 2024
- End date
- Jan 31, 2025
- Enrollment
- 60 participants
Patients' decisional conflict regarding EOL care
This study aims to test the effects of a patient decision aid (PDA) on planning for
 end-of-life (EOL) care among older adults with COPD. The main questions it aims to answer
 are:
 
 1. Does a PDA improve the process of a person to make decisions on EOL care?
 
 2. Does a PDA improve the readiness of a person to join advance care planning (ACP)
 communication?
 
 3. Does a person make an advance directive after using a PDA?
 
 Participants in this study will:
 
 1. Be randomly assigned to one of two groups.
 
 2. In the experimental group, participants will receive two 60-minute interactive
 consultations over four weeks, using a PDA to help clarify values and preferences for
 future medical care. A guidebook summarising these future care options will be provided.
 
 3. In the control group, participants will receive two 60-minute sessions on lifestyle
 modification and self-care management over four weeks using a guidebook with coaching. A
 guidebook summarising general health information will be provided.
 
 Researchers will compare the intervention group to the control group to see if the PDA is
 better at improving the decision-making process on EOL care, the readiness of a person to
 join ACP communication and the chance to make an advance directive.
- Registry
- ClinicalTrials.gov
- Trial ID
- NCT06314035
- Type
- Non-Device Trial
Access comprehensive clinical trial information for NCT06314035 through Pure Global AI's free database. This phase not specified trial is sponsored by National Taipei University of Nursing and Health Sciences and is currently Not yet recruiting. The study focuses on Chronic Obstructive Pulmonary Disease. Target enrollment is 60 participants.
This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.